Structure

Physi-Chem Properties

Molecular Weight:  580.16
Volume:  564.419
LogP:  2.744
LogD:  1.857
LogS:  -3.243
# Rotatable Bonds:  10
TPSA:  203.44
# H-Bond Aceptor:  12
# H-Bond Donor:  7
# Rings:  4
# Heavy Atoms:  12

MedChem Properties

QED Drug-Likeness Score:  0.084
Synthetic Accessibility Score:  4.128
Fsp3:  0.2
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  2
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.437
MDCK Permeability:  9.986570148612373e-06
Pgp-inhibitor:  0.012
Pgp-substrate:  0.038
Human Intestinal Absorption (HIA):  0.338
20% Bioavailability (F20%):  0.548
30% Bioavailability (F30%):  0.999

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.05
Plasma Protein Binding (PPB):  101.7306900024414%
Volume Distribution (VD):  0.563
Pgp-substrate:  0.7776962518692017%

ADMET: Metabolism

CYP1A2-inhibitor:  0.425
CYP1A2-substrate:  0.015
CYP2C19-inhibitor:  0.162
CYP2C19-substrate:  0.052
CYP2C9-inhibitor:  0.653
CYP2C9-substrate:  0.518
CYP2D6-inhibitor:  0.458
CYP2D6-substrate:  0.27
CYP3A4-inhibitor:  0.433
CYP3A4-substrate:  0.146

ADMET: Excretion

Clearance (CL):  6.968
Half-life (T1/2):  0.943

ADMET: Toxicity

hERG Blockers:  0.161
Human Hepatotoxicity (H-HT):  0.222
Drug-inuced Liver Injury (DILI):  0.487
AMES Toxicity:  0.663
Rat Oral Acute Toxicity:  0.435
Maximum Recommended Daily Dose:  0.018
Skin Sensitization:  0.962
Carcinogencity:  0.359
Eye Corrosion:  0.003
Eye Irritation:  0.238
Respiratory Toxicity:  0.029

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC149011

Natural Product ID:  NPC149011
Common Name*:   4'-O-Beta-D-(2''-P-Coumaroyl)Glucopyranosyl-4,2',3'-Trihydroxychalcone
IUPAC Name:   [(2S,3R,4S,5S,6R)-2-[2,3-dihydroxy-4-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]phenoxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl] (E)-3-(4-hydroxyphenyl)prop-2-enoate
Synonyms:  
Standard InCHIKey:  XKPBAPHWYIKWSN-SVQBVAIGSA-N
Standard InCHI:  InChI=1S/C30H28O12/c31-15-23-27(38)28(39)29(42-24(35)14-6-17-3-9-19(33)10-4-17)30(41-23)40-22-13-11-20(25(36)26(22)37)21(34)12-5-16-1-7-18(32)8-2-16/h1-14,23,27-33,36-39H,15H2/b12-5+,14-6+/t23-,27-,28+,29-,30-/m1/s1
SMILES:  OC[C@H]1O[C@@H](Oc2ccc(c(c2O)O)C(=O)/C=C/c2ccc(cc2)O)[C@@H]([C@H]([C@@H]1O)O)OC(=O)/C=C/c1ccc(cc1)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL504292
PubChem CID:   11827998
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0001111] Flavonoid glycosides
          • [CHEMONTID:0001583] Flavonoid O-glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO27239 Maclura tinctoria Species Moraceae Eukaryota n.a. n.a. n.a. PMID[11087602]
NPO27239 Maclura tinctoria Species Moraceae Eukaryota n.a. n.a. n.a. PMID[12932124]
NPO27239 Maclura tinctoria Species Moraceae Eukaryota n.a. stem n.a. PMID[12932124]
NPO27239 Maclura tinctoria Species Moraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Activity = 1.93 mM PMID[544967]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC149011 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC204937
0.9876 High Similarity NPC88560
0.9876 High Similarity NPC175230
0.9876 High Similarity NPC172033
0.9755 High Similarity NPC472991
0.9755 High Similarity NPC472992
0.9753 High Similarity NPC472993
0.975 High Similarity NPC116745
0.9695 High Similarity NPC476620
0.9695 High Similarity NPC476621
0.9695 High Similarity NPC476618
0.9695 High Similarity NPC476623
0.9695 High Similarity NPC476619
0.9695 High Similarity NPC476622
0.9691 High Similarity NPC47140
0.9691 High Similarity NPC67134
0.9686 High Similarity NPC88043
0.9634 High Similarity NPC144097
0.9634 High Similarity NPC61904
0.9627 High Similarity NPC45400
0.9625 High Similarity NPC165720
0.9576 High Similarity NPC37668
0.9576 High Similarity NPC217520
0.9576 High Similarity NPC472387
0.9576 High Similarity NPC139571
0.9576 High Similarity NPC35167
0.9576 High Similarity NPC113836
0.9576 High Similarity NPC253521
0.9573 High Similarity NPC223426
0.9573 High Similarity NPC81042
0.9573 High Similarity NPC34267
0.9573 High Similarity NPC214621
0.9571 High Similarity NPC172807
0.9571 High Similarity NPC211594
0.9571 High Similarity NPC254540
0.9568 High Similarity NPC229687
0.9563 High Similarity NPC270335
0.9563 High Similarity NPC168822
0.9563 High Similarity NPC191306
0.9521 High Similarity NPC36138
0.9518 High Similarity NPC471030
0.9515 High Similarity NPC296018
0.9515 High Similarity NPC154741
0.9512 High Similarity NPC4390
0.9509 High Similarity NPC20505
0.9509 High Similarity NPC34287
0.9509 High Similarity NPC235260
0.9509 High Similarity NPC471416
0.9509 High Similarity NPC155763
0.9506 High Similarity NPC58716
0.9506 High Similarity NPC229729
0.9506 High Similarity NPC146792
0.9506 High Similarity NPC45618
0.9503 High Similarity NPC22832
0.9503 High Similarity NPC311830
0.95 High Similarity NPC77660
0.95 High Similarity NPC189142
0.95 High Similarity NPC285108
0.95 High Similarity NPC33298
0.9497 High Similarity NPC289346
0.9464 High Similarity NPC470416
0.9458 High Similarity NPC258044
0.9458 High Similarity NPC267680
0.9458 High Similarity NPC293626
0.9458 High Similarity NPC477895
0.9458 High Similarity NPC476773
0.9458 High Similarity NPC217387
0.9458 High Similarity NPC196127
0.9455 High Similarity NPC135277
0.9455 High Similarity NPC49344
0.9455 High Similarity NPC43211
0.9455 High Similarity NPC101191
0.9455 High Similarity NPC210094
0.9455 High Similarity NPC477848
0.9455 High Similarity NPC237435
0.9455 High Similarity NPC115760
0.9451 High Similarity NPC307518
0.9451 High Similarity NPC190003
0.9451 High Similarity NPC175107
0.9451 High Similarity NPC153755
0.9451 High Similarity NPC48773
0.9451 High Similarity NPC472386
0.9451 High Similarity NPC205076
0.9448 High Similarity NPC226294
0.9448 High Similarity NPC112755
0.9448 High Similarity NPC58053
0.9448 High Similarity NPC138927
0.9448 High Similarity NPC186807
0.9448 High Similarity NPC475942
0.9448 High Similarity NPC471457
0.9448 High Similarity NPC105025
0.9448 High Similarity NPC469931
0.9448 High Similarity NPC201292
0.9448 High Similarity NPC45638
0.9448 High Similarity NPC170675
0.9448 High Similarity NPC93337
0.9444 High Similarity NPC197285
0.9444 High Similarity NPC21100
0.9444 High Similarity NPC236934
0.9444 High Similarity NPC5778
0.9441 High Similarity NPC222936
0.9441 High Similarity NPC88023
0.9441 High Similarity NPC29830
0.9441 High Similarity NPC243930
0.9441 High Similarity NPC284960
0.9441 High Similarity NPC19709
0.9441 High Similarity NPC309025
0.9405 High Similarity NPC135831
0.9405 High Similarity NPC199172
0.9405 High Similarity NPC297503
0.9405 High Similarity NPC35924
0.9405 High Similarity NPC97119
0.9405 High Similarity NPC470718
0.9398 High Similarity NPC472385
0.9398 High Similarity NPC198324
0.9398 High Similarity NPC211532
0.9398 High Similarity NPC268533
0.9398 High Similarity NPC233994
0.939 High Similarity NPC231194
0.939 High Similarity NPC44558
0.939 High Similarity NPC206123
0.939 High Similarity NPC116864
0.939 High Similarity NPC72249
0.939 High Similarity NPC105511
0.939 High Similarity NPC282987
0.939 High Similarity NPC183357
0.939 High Similarity NPC84265
0.939 High Similarity NPC22195
0.939 High Similarity NPC474434
0.939 High Similarity NPC245014
0.939 High Similarity NPC51326
0.939 High Similarity NPC244776
0.939 High Similarity NPC224462
0.939 High Similarity NPC212748
0.939 High Similarity NPC21190
0.9383 High Similarity NPC277205
0.9379 High Similarity NPC300537
0.9379 High Similarity NPC90905
0.9379 High Similarity NPC127782
0.9379 High Similarity NPC4013
0.9379 High Similarity NPC473043
0.9375 High Similarity NPC203020
0.9375 High Similarity NPC239966
0.9349 High Similarity NPC25946
0.9349 High Similarity NPC470720
0.9349 High Similarity NPC21359
0.9349 High Similarity NPC460984
0.9349 High Similarity NPC470713
0.9349 High Similarity NPC231254
0.9349 High Similarity NPC470717
0.9345 High Similarity NPC469371
0.9341 High Similarity NPC267549
0.9337 High Similarity NPC264735
0.9337 High Similarity NPC253685
0.9333 High Similarity NPC117260
0.9333 High Similarity NPC235575
0.9333 High Similarity NPC3583
0.9333 High Similarity NPC259152
0.9333 High Similarity NPC476405
0.9329 High Similarity NPC120099
0.9329 High Similarity NPC209296
0.9329 High Similarity NPC203050
0.9329 High Similarity NPC472383
0.9329 High Similarity NPC95855
0.9329 High Similarity NPC223747
0.9329 High Similarity NPC219904
0.9329 High Similarity NPC183036
0.9329 High Similarity NPC472381
0.9329 High Similarity NPC225434
0.9329 High Similarity NPC86008
0.9329 High Similarity NPC195257
0.9329 High Similarity NPC210042
0.9325 High Similarity NPC115674
0.9325 High Similarity NPC179950
0.9325 High Similarity NPC274618
0.9325 High Similarity NPC281131
0.9325 High Similarity NPC56077
0.9325 High Similarity NPC210073
0.9325 High Similarity NPC308404
0.9325 High Similarity NPC145038
0.9325 High Similarity NPC253662
0.9325 High Similarity NPC88789
0.9325 High Similarity NPC8856
0.9325 High Similarity NPC276222
0.9325 High Similarity NPC118284
0.9321 High Similarity NPC121290
0.9317 High Similarity NPC270675
0.9317 High Similarity NPC477628
0.9317 High Similarity NPC472994
0.9317 High Similarity NPC210961
0.9317 High Similarity NPC477629
0.9317 High Similarity NPC182045
0.9317 High Similarity NPC195685
0.9313 High Similarity NPC160780
0.9313 High Similarity NPC289811
0.9294 High Similarity NPC104910
0.9294 High Similarity NPC474093
0.9294 High Similarity NPC473554
0.9294 High Similarity NPC470719
0.9294 High Similarity NPC295625

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC149011 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9455 High Similarity NPD4338 Clinical (unspecified phase)
0.9387 High Similarity NPD3818 Discontinued
0.9329 High Similarity NPD7054 Approved
0.9273 High Similarity NPD7472 Approved
0.9273 High Similarity NPD7074 Phase 3
0.9187 High Similarity NPD4868 Clinical (unspecified phase)
0.913 High Similarity NPD4381 Clinical (unspecified phase)
0.9102 High Similarity NPD6797 Phase 2
0.9048 High Similarity NPD7251 Discontinued
0.903 High Similarity NPD6167 Clinical (unspecified phase)
0.903 High Similarity NPD6166 Phase 2
0.903 High Similarity NPD6168 Clinical (unspecified phase)
0.8994 High Similarity NPD7808 Phase 3
0.8882 High Similarity NPD1934 Approved
0.8765 High Similarity NPD7993 Clinical (unspecified phase)
0.8712 High Similarity NPD2801 Approved
0.8712 High Similarity NPD2393 Clinical (unspecified phase)
0.8659 High Similarity NPD3817 Phase 2
0.8606 High Similarity NPD3882 Suspended
0.8605 High Similarity NPD6559 Discontinued
0.8538 High Similarity NPD7804 Clinical (unspecified phase)
0.8528 High Similarity NPD4380 Phase 2
0.85 High Similarity NPD1511 Approved
0.8443 Intermediate Similarity NPD7075 Discontinued
0.8434 Intermediate Similarity NPD5402 Approved
0.843 Intermediate Similarity NPD5844 Phase 1
0.8405 Intermediate Similarity NPD1653 Approved
0.8395 Intermediate Similarity NPD1512 Approved
0.8373 Intermediate Similarity NPD1465 Phase 2
0.8364 Intermediate Similarity NPD7411 Suspended
0.8353 Intermediate Similarity NPD6232 Discontinued
0.8344 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.8314 Intermediate Similarity NPD7473 Discontinued
0.8295 Intermediate Similarity NPD8312 Approved
0.8295 Intermediate Similarity NPD8313 Approved
0.8263 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8235 Intermediate Similarity NPD5494 Approved
0.8232 Intermediate Similarity NPD5403 Approved
0.8204 Intermediate Similarity NPD6801 Discontinued
0.8187 Intermediate Similarity NPD1549 Phase 2
0.8187 Intermediate Similarity NPD7199 Phase 2
0.8182 Intermediate Similarity NPD7685 Pre-registration
0.8177 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.8167 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.8161 Intermediate Similarity NPD7228 Approved
0.816 Intermediate Similarity NPD6799 Approved
0.8155 Intermediate Similarity NPD7819 Suspended
0.8125 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8125 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.811 Intermediate Similarity NPD5401 Approved
0.8107 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.807 Intermediate Similarity NPD6234 Discontinued
0.8057 Intermediate Similarity NPD3751 Discontinued
0.8046 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8012 Intermediate Similarity NPD3749 Approved
0.8 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7989 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7988 Intermediate Similarity NPD37 Approved
0.7977 Intermediate Similarity NPD6959 Discontinued
0.7953 Intermediate Similarity NPD4967 Phase 2
0.7953 Intermediate Similarity NPD4966 Approved
0.7953 Intermediate Similarity NPD4965 Approved
0.7939 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7931 Intermediate Similarity NPD3787 Discontinued
0.7927 Intermediate Similarity NPD6190 Approved
0.7917 Intermediate Similarity NPD8151 Discontinued
0.7901 Intermediate Similarity NPD7266 Discontinued
0.7892 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7888 Intermediate Similarity NPD1510 Phase 2
0.787 Intermediate Similarity NPD6599 Discontinued
0.7866 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7849 Intermediate Similarity NPD7768 Phase 2
0.784 Intermediate Similarity NPD2796 Approved
0.7836 Intermediate Similarity NPD8455 Phase 2
0.7812 Intermediate Similarity NPD1933 Approved
0.7812 Intermediate Similarity NPD230 Phase 1
0.7758 Intermediate Similarity NPD3750 Approved
0.775 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.775 Intermediate Similarity NPD943 Approved
0.775 Intermediate Similarity NPD1613 Approved
0.7749 Intermediate Similarity NPD7435 Discontinued
0.773 Intermediate Similarity NPD1551 Phase 2
0.7702 Intermediate Similarity NPD447 Suspended
0.7697 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7684 Intermediate Similarity NPD6776 Approved
0.7684 Intermediate Similarity NPD6782 Approved
0.7684 Intermediate Similarity NPD6779 Approved
0.7684 Intermediate Similarity NPD6777 Approved
0.7684 Intermediate Similarity NPD3926 Phase 2
0.7684 Intermediate Similarity NPD6781 Approved
0.7684 Intermediate Similarity NPD6778 Approved
0.7684 Intermediate Similarity NPD6780 Approved
0.768 Intermediate Similarity NPD7240 Approved
0.7657 Intermediate Similarity NPD919 Approved
0.7653 Intermediate Similarity NPD7783 Phase 2
0.7653 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7651 Intermediate Similarity NPD4628 Phase 3
0.764 Intermediate Similarity NPD1240 Approved
0.7636 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7574 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7546 Intermediate Similarity NPD1607 Approved
0.7538 Intermediate Similarity NPD7584 Approved
0.7526 Intermediate Similarity NPD7871 Phase 2
0.7526 Intermediate Similarity NPD7870 Phase 2
0.7526 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7516 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7515 Intermediate Similarity NPD2935 Discontinued
0.7513 Intermediate Similarity NPD7874 Approved
0.7513 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD3226 Approved
0.7474 Intermediate Similarity NPD7697 Approved
0.7474 Intermediate Similarity NPD7698 Approved
0.7474 Intermediate Similarity NPD7696 Phase 3
0.7472 Intermediate Similarity NPD1247 Approved
0.7471 Intermediate Similarity NPD2533 Approved
0.7471 Intermediate Similarity NPD2532 Approved
0.7471 Intermediate Similarity NPD2534 Approved
0.7455 Intermediate Similarity NPD3748 Approved
0.7453 Intermediate Similarity NPD3027 Phase 3
0.7438 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7432 Intermediate Similarity NPD5953 Discontinued
0.7423 Intermediate Similarity NPD6823 Phase 2
0.7421 Intermediate Similarity NPD6534 Approved
0.7421 Intermediate Similarity NPD6535 Approved
0.7411 Intermediate Similarity NPD7701 Phase 2
0.7399 Intermediate Similarity NPD7458 Discontinued
0.7399 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7385 Intermediate Similarity NPD7680 Approved
0.7384 Intermediate Similarity NPD920 Approved
0.738 Intermediate Similarity NPD8150 Discontinued
0.7368 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7358 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7349 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7347 Intermediate Similarity NPD8319 Approved
0.7347 Intermediate Similarity NPD8320 Phase 1
0.7323 Intermediate Similarity NPD7585 Approved
0.7322 Intermediate Similarity NPD7286 Phase 2
0.732 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7312 Intermediate Similarity NPD1203 Approved
0.7306 Intermediate Similarity NPD7700 Phase 2
0.7306 Intermediate Similarity NPD7699 Phase 2
0.7301 Intermediate Similarity NPD2313 Discontinued
0.73 Intermediate Similarity NPD7801 Approved
0.7288 Intermediate Similarity NPD5353 Approved
0.7287 Intermediate Similarity NPD8434 Phase 2
0.7284 Intermediate Similarity NPD6832 Phase 2
0.7273 Intermediate Similarity NPD7583 Approved
0.7262 Intermediate Similarity NPD2346 Discontinued
0.7251 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7246 Intermediate Similarity NPD2799 Discontinued
0.7233 Intermediate Similarity NPD9269 Phase 2
0.7233 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD9494 Approved
0.7204 Intermediate Similarity NPD7038 Approved
0.7204 Intermediate Similarity NPD7039 Approved
0.7198 Intermediate Similarity NPD5242 Approved
0.7195 Intermediate Similarity NPD6798 Discontinued
0.7188 Intermediate Similarity NPD6212 Phase 3
0.7188 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7188 Intermediate Similarity NPD6213 Phase 3
0.7182 Intermediate Similarity NPD8127 Discontinued
0.7178 Intermediate Similarity NPD4908 Phase 1
0.7176 Intermediate Similarity NPD6674 Discontinued
0.7176 Intermediate Similarity NPD2800 Approved
0.7176 Intermediate Similarity NPD1243 Approved
0.717 Intermediate Similarity NPD1091 Approved
0.7169 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.716 Intermediate Similarity NPD2344 Approved
0.7152 Intermediate Similarity NPD6233 Phase 2
0.7143 Intermediate Similarity NPD7033 Discontinued
0.7135 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.712 Intermediate Similarity NPD4287 Approved
0.7119 Intermediate Similarity NPD6385 Approved
0.7119 Intermediate Similarity NPD6386 Approved
0.711 Intermediate Similarity NPD7390 Discontinued
0.7091 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.709 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7081 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7081 Intermediate Similarity NPD5619 Clinical (unspecified phase)
0.7079 Intermediate Similarity NPD6844 Discontinued
0.7076 Intermediate Similarity NPD1652 Phase 2
0.7074 Intermediate Similarity NPD7549 Discontinued
0.7071 Intermediate Similarity NPD5005 Approved
0.7071 Intermediate Similarity NPD5006 Approved
0.7069 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7065 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7063 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7049 Intermediate Similarity NPD5710 Approved
0.7049 Intermediate Similarity NPD5711 Approved
0.7049 Intermediate Similarity NPD7229 Phase 3
0.7041 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7022 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7019 Intermediate Similarity NPD9717 Approved
0.7 Intermediate Similarity NPD6099 Approved
0.7 Intermediate Similarity NPD5408 Approved
0.7 Intermediate Similarity NPD5405 Approved
0.7 Intermediate Similarity NPD5404 Approved
0.7 Intermediate Similarity NPD6100 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data